It is well established that MCP-1 release is controlled by interleukin-18 (IL-18) and extracellular signal-regulated kinase 1/2 (ERK1/2) [16], and the levels of MCP-1 are higher in patients with sepsis, septic shock, and pneumonia [17,18]. The gene discussed is CCL2; the disease is susceptibility to pneumonia measurement.